Cas No.: 2031154-77-3
PRODUCT INFORMATION
Description
LinTT1 (sequence: AKRGARST) is a tumor-penetrating peptide that targets the p32 receptor (C1QBP), which is upregulated in various cancer models, including peritoneal carcinoma. It is used as a research tool to functionalize nanocarriers, enabling the study of mitochondrial-targeted delivery. This peptide has been investigated for its role in preclinical models, focusing on its ability to home to p32-expressing cells.
Molecular Weight
917.03
Purity
> 95%
Formula
C₃₆H₆₈N₁₆O₁₂
Product Type
Targeting Peptide
Sequence
Ala-Lys-Arg-Gly-Ala-Arg-Ser-Thr-Ala
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- PSMA Targeting Peptide (CAT#: OLY-1025-YS-8)
- Cyclo(Arg-Ala-Asp-(D-Tyr)-Lys) Targeting Peptide (CAT#: OLY-1025-YS-36)
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- NGR Targeting Peptide (CAT#: OLY-1025-YS-38)
- IRGD Peptide 1 TFA (CAT#: OLY-1025-YS-58)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- Aminopeptidase N Ligand (CD13) NGR Targeting Peptide (CAT#: OLY-1025-YS-10)
- VSLRGDTRG Targeting Peptide (CAT#: OLY-1025-YS-32)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.